1 |
Han Z, Qian Y, Gao X, Yang D, Cai Y, Chen Y, Jin J, Yang Z. Hypoxia-responsive covalent organic framework by single NIR laser-triggered for multimodal synergistic therapy of triple-negative breast cancer. Colloids Surf B Biointerfaces 2023;222:113094. [PMID: 36535221 DOI: 10.1016/j.colsurfb.2022.113094] [Reference Citation Analysis]
|
2 |
Ye J, Li R, Cheng J, Liu D, Yang Y, Wang H, Xu X, Li L, Ma P, Liu Y. Comparative Colloidal Stability of Commercial Amphotericin B Nanoformulations Using Dynamic and Static Multiple Light Scattering Techniques. Int J Nanomedicine 2022;17:6047-64. [PMID: 36510621 DOI: 10.2147/IJN.S387681] [Reference Citation Analysis]
|
3 |
Zhang W, Xu Y, Shi X, Huang X, Chen R, Xu H, Shi W, Wan X, Wang Y, He J, Li C, Wang J, Zha X. Nanoparticle albumin-bound paclitaxel is superior to liposomal paclitaxel in the neoadjuvant treatment of breast cancer. Nanomedicine (Lond) 2022. [PMID: 35393861 DOI: 10.2217/nnm-2022-0025] [Reference Citation Analysis]
|
4 |
Rapozzi V, Moret F, Menilli L, Guerrini A, Tedesco D, Naldi M, Bartolini M, Gani M, Zorzet S, Columbaro M, Milani C, Martini C, Ferroni C, Varchi G. HSA-Binding Prodrugs-Based Nanoparticles Endowed with Chemo and Photo-Toxicity against Breast Cancer. Cancers (Basel) 2022;14:877. [PMID: 35205627 DOI: 10.3390/cancers14040877] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
|